Orphan Drug Designation Granted By FDA For This Medical Tech Company

FDA Grants Orphan Drug Designation to Creative Medical Technology's CELZ-101: A Major Breakthrough in Transplantation Therapy.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In a significant development that could potentially revolutionize transplantation therapy, Creative Medical Technology Holdings, Inc. has received the FDA's Orphan Drug Designation for its innovative drug, CELZ…